Invectys to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference Houston, Texas, USA, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Invectys Inc. will participate in the H.C. Wainwright Bioconnect Virtual Conference January 10-13, 2022.  Praveen Tyle, Ph.D., Invectys Inc....

INVECTYS INC. TO PARTICIPATE IN THE 2022 JP MORGAN HEALTHCARE MEETING AND BIOTECH SHOWCASE, JANUARY 10-19, 2022  Houston, Texas, USA, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development of a new generation of products...

INVECTYS INC. TO PARTICIPATE IN THE 2021 H.C. WAINWRIGHT 23rd ANNUAL GLOBAL INVESTMENT CONFERENCE SEPTEMBER 13-15, 2021 Houston, Texas, USA, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development of a new generation of products...

INVECTYS INC. TO PARTICIPATE IN THE 2021 ROTH VIRTUAL HEALTHCARE PRIVATE COMPANY FORUM ON JUNE 28TH, 2021 Houston, Texas, USA, June 25, 2021 (GLOBE NEWSWIRE) -- Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development of a new generation of products...

Invectys nominates Rosemary Williams, CPA, as Vice-President for Administration and Controller Houston, TX, USA, June 01, 2021 (GLOBE NEWSWIRE) -- Invectys Inc. of Houston, Texas, a clinical stage immunotherapy company dedicated to the development of a next generation of therapies to meet the...